TAVR, SAVR Show Comparable 1-Year Mortality Results in UK TAVI Trial
Transcatheter aortic valve replacement (TAVR) was shown to be non-inferior to surgical aortic valve replacement (SAVR) in terms of mortality in patients age 70 and older deemed to be at increased surgical mortality risk, according to late-breaking trial results presented Sunday at the American College of Cardiology Scientific Sessions 2020 virtual conference.